<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T02:13:40Z</responseDate>
  <request identifier="oai:figshare.com:article/34022540" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34022540</identifier>
        <datestamp>2026-09-29T10:06:28Z</datestamp>
        <setSpec>category_13</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Twin study: genotype-dependent epigenetic factors associated with HbA1c levels</dc:title>
          <dc:creator>Hinako Hashimoto (9444715)</dc:creator>
          <dc:creator>Yuya Arakawa (8479635)</dc:creator>
          <dc:creator>Ritsuko Ozaki (25136480)</dc:creator>
          <dc:creator>Mika Hasegawa (17838718)</dc:creator>
          <dc:creator>Shiho Kato (17838721)</dc:creator>
          <dc:creator>Saho Mori (17838724)</dc:creator>
          <dc:creator>Saki Yoshioka (17838716)</dc:creator>
          <dc:creator>Hiromichi Ueda (17838725)</dc:creator>
          <dc:creator>Osaka Twin Research Group (25136483)</dc:creator>
          <dc:creator>Mikio Watanabe (3520973)</dc:creator>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Hemoglobin A1C (HbA1c)</dc:subject>
          <dc:subject>twin study</dc:subject>
          <dc:subject>single nucleotide variants (SNVs)</dc:subject>
          <dc:subject>DNA methylation</dc:subject>
          <dc:subject>Genome-wide association study</dc:subject>
          <dc:description>&lt;p&gt;Hemoglobin A1c (HbA1c) is a biomarker for diabetes mellitus. Twin studies suggest substantial heritability, but the molecular basis of non-genetic variation remains unclear. We aimed to explore genetic and epigenetic factors associated with HbA1c through multi-omics analysis of monozygotic twins.&lt;/p&gt; &lt;p&gt;A total of 285 monozygotic and 27 dizygotic twin pairs were enrolled in Japan. Genome-wide single-nucleotide variant (SNV) genotyping, DNA methylation profiling, and RNA sequencing were performed. Based on HbA1c levels, twin pairs were classified as high concordant, low concordant, or discordant. Structural equation modeling estimated heritability, and GWAS, within-pair methylation comparisons, and expression–methylation correlation analyses were conducted.&lt;/p&gt; &lt;p&gt;Our analysis estimated that genetic factors accounted for 68% of the phenotypic variance in covariate-adjusted HbA1c. Within-pair methylation comparisons revealed several suggestive CpG sites associated with HbA1c variation. GWAS revealed one suggestive SNV associated with higher HbA1c and three SNVs potentially associated with susceptibility to HbA1c variation. Genotype-stratified analyses showed exploratory genetic background–dependent methylation changes at CpG sites, some of which correlated with gene expression.&lt;/p&gt; &lt;p&gt;This study estimated the heritability of adjusted HbA1c and revealed preliminary genetic and epigenetic signals in Japanese twins. Further studies are needed to confirm their biological and clinical significance.&lt;/p&gt; &lt;p&gt;HbA1c is a blood marker that reflects average blood sugar levels over the past few months. Doctors use it to diagnose and monitor diabetes. Earlier twin studies showed that genes strongly influence HbA1c levels, but scientists do not fully understand how non-genetic factors, such as chemical changes to DNA called methylation, might also play a role.We studied 285 identical (genetically matched) and 27 non-identical Japanese twin pairs. We measured their genetic makeup, DNA methylation patterns, and gene activity, then compared these measurements with their HbA1c levels. Our analysis estimated that genetic factors account for about 68% of the differences in HbA1c levels among adults, after adjusting for lifestyle factors. We also found several DNA methylation sites and genetic variants that may be associated with HbA1c differences between twins. However, none of these associations reached the strict statistical thresholds normally required to confirm a genome-wide finding. We therefore describe them as candidate, or suggestive, factors rather than confirmed ones. These early findings offer clues about how genes and epigenetic changes might jointly influence blood sugar regulation. They are not yet strong enough to guide clinical decisions. Larger studies will be needed to test whether these candidate genetic and epigenetic factors are real and whether they could eventually help personalize diabetes prevention or care.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T10:06:28Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34022540.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Twin_study_genotype-dependent_epigenetic_factors_associated_with_HbA1c_levels/34022540</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
